Author:
Moynihan Eoin,Bassi Giada,Ruffini Andrea,Panseri Silvia,Montesi Monica,Velasco-Torrijos Trinidad,Montagner Diego
Abstract
The selectivity vs. cancer cells has always been a major challenge for chemotherapeutic agents and in particular for cisplatin, one of the most important anticancer drugs for the treatment of several types of tumors. One strategy to overtake this challenge is to modify the coordination sphere of the metallic center with specific vectors whose receptors are overexpressed in the tumoral cell membrane, such as monosaccharides. In this paper, we report the synthesis of four novel glyco-modified Pt(IV) pro-drugs, based on cisplatin scaffold, and their biological activity against osteosarcoma (OS), a malignant tumor affecting in particular adolescents and young adults. The sugar moiety and the Pt scaffold are linked exploiting the Copper Azide Alkyne Cycloaddition (CUAAC) reaction, which has become the flagship of click chemistry due to its versatility and mild conditions. Cytotoxicity and drug uptake on three different OS cell lines as well as CSCs (Cancer Stem Cell) are described.
Funder
H2020 Spreading Excellence and Widening Participation
Reference56 articles.
1. Pt(IV) Pro-drugs with an Axial HDAC Inhibitor Demonstrate Multimodal Mechanisms Involving DNA Damage and Apoptosis Independent of Cisplatin Resistance in A2780/A2780cis Cells;Almotairy;J. Inorg. Biochem.,2020
2. Scaffold-based 3D Cellular Models Mimicking the Heterogeneity of Osteosarcoma Stem Cell Niche;Bassi;Sci. Rep.,2020
3. The 1,2,3-triazole Ring as a Bioisostere in Medicinal Chemistry;Bonandi;Drug Discov. Today,2017
4. Microtubules in 3D Cell Motility;Bouchet;J. Cel Sci.,2017
5. Synthesis, Characterization, and Properties, of a Group of Platinum(IV) Complexes;Brandon;J. Med. Chem.,1984
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献